CHAMPIONS ONCOLOGY, INC. Quarterly Common Stock, Shares, Outstanding from Q1 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Champions Oncology, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q1 2011 to Q3 2024.
  • Champions Oncology, Inc. Common Stock, Shares, Outstanding for the quarter ending October 31, 2024 was 13.7M shares, a 0.77% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 13.7M +105K +0.77% Oct 31, 2024 10-Q 2024-12-16
Q2 2024 13.6M +110K +0.81% Jul 31, 2024 10-Q 2024-09-13
Q1 2024 13.6M +49.5K +0.37% Apr 30, 2024 10-Q 2024-12-16
Q4 2023 13.6M +35.1K +0.26% Jan 31, 2024 10-Q 2024-03-15
Q3 2023 13.6M +35.1K +0.26% Oct 31, 2023 10-Q 2023-12-13
Q2 2023 13.5M -38.3K -0.28% Jul 31, 2023 10-Q 2023-09-13
Q1 2023 13.5M +21.8K +0.16% Apr 30, 2023 10-K 2024-07-19
Q4 2022 13.6M +40.7K +0.3% Jan 31, 2023 10-Q 2023-03-16
Q3 2022 13.6M +62.5K +0.46% Oct 31, 2022 10-Q 2022-12-13
Q2 2022 13.5M +107K +0.8% Jul 31, 2022 10-Q 2022-09-12
Q1 2022 13.5M +108K +0.81% Apr 30, 2022 10-K 2023-07-24
Q4 2021 13.5M +128K +0.95% Jan 31, 2022 10-Q 2022-03-15
Q3 2021 13.5M +128K +0.95% Oct 31, 2021 10-Q 2021-12-13
Q2 2021 13.4M +687K +5.4% Jul 31, 2021 10-Q 2021-09-13
Q1 2021 13.4M +687K +5.4% Apr 30, 2021 10-K 2022-07-22
Q4 2020 13.4M +1.77M +15.2% Jan 31, 2021 10-Q 2021-03-15
Q3 2020 13.4M +1.75M +15% Oct 31, 2020 10-Q 2020-12-14
Q2 2020 12.7M +1.11M +9.54% Jul 31, 2020 10-Q 2020-09-14
Q1 2020 12.7M +1.11M +9.53% Apr 30, 2020 10-K 2021-07-26
Q4 2019 11.6M +6.84K +0.06% Jan 31, 2020 10-Q 2020-03-16
Q3 2019 11.6M +145K +1.27% Oct 31, 2019 10-Q 2019-12-16
Q2 2019 11.6M +592K +5.36% Jul 31, 2019 10-Q 2019-09-16
Q1 2019 11.6M +616K +5.6% Apr 30, 2019 10-K 2020-07-28
Q4 2018 11.6M +612K +5.56% Jan 31, 2019 10-Q 2019-03-18
Q3 2018 11.5M +486K +4.43% Oct 31, 2018 10-Q 2018-12-17
Q2 2018 11M +45.8K +0.42% Jul 31, 2018 10-Q 2018-09-14
Q1 2018 11M +21.1K +0.19% Apr 30, 2018 10-K 2019-07-29
Q4 2017 11M +33.4K +0.3% Jan 31, 2018 10-Q 2018-03-19
Q3 2017 11M +20.9K +0.19% Oct 31, 2017 10-Q 2017-12-15
Q2 2017 11M +14.7K +0.13% Jul 31, 2017 10-Q 2017-09-14
Q1 2017 11M +2.28M +26.2% Apr 30, 2017 10-K 2018-07-30
Q4 2016 11M +2M +22.4% Jan 31, 2017 10-Q 2017-03-17
Q3 2016 11M +2.27M +26% Oct 31, 2016 10-Q 2016-12-14
Q2 2016 11M +2.27M +26% Jul 31, 2016 10-Q 2016-09-14
Q1 2016 8.7M +12.2K +0.14% Apr 30, 2016 10-K 2017-07-28
Q4 2015 8.96M -57.9M -86.6% Jan 31, 2016 10-Q 2016-03-16
Q3 2015 8.7M -58.2M -87% Oct 31, 2015 10-Q 2015-12-15
Q2 2015 8.7M -58.2M -87% Jul 31, 2015 10-Q 2015-09-11
Q1 2015 8.69M -58.2M -87% Apr 30, 2015 10-K 2016-07-29
Q4 2014 66.9M +22.5K +0.03% Jan 31, 2015 10-Q 2015-03-17
Q3 2014 66.9M +31.2M +87.2% Oct 31, 2014 10-Q 2014-12-15
Q2 2014 66.9M +31.2M +87.3% Jul 31, 2014 10-Q 2014-09-12
Q1 2014 66.9M +31.2M +87.7% Apr 30, 2014 10-K 2015-07-29
Q4 2013 66.9M +31.2M +87.7% Jan 31, 2014 10-Q 2014-03-14
Q3 2013 35.7M +1.23M +3.56% Oct 31, 2013 10-Q 2013-12-13
Q2 2013 35.7M +1.21M +3.52% Jul 31, 2013 10-Q 2013-09-13
Q1 2013 35.6M +1.11M +3.23% Apr 30, 2013 10-K 2014-07-28
Q4 2012 35.6M +1.14M +3.31% Jan 31, 2013 10-Q 2013-03-13
Q3 2012 34.5M +39.1K +0.11% Oct 31, 2012 10-Q 2012-12-13
Q2 2012 34.5M +574K +1.69% Jul 31, 2012 10-Q 2012-09-12
Q1 2012 34.5M +659K +1.95% Apr 30, 2012 10-K 2013-07-26
Q4 2011 34.5M Jan 31, 2012 10-Q 2012-03-14
Q3 2011 34.5M Oct 31, 2011 10-Q 2011-12-14
Q2 2011 33.9M Jul 31, 2011 10-Q 2011-09-13
Q1 2011 33.9M Apr 30, 2011 10-K 2012-07-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.